Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 113 of 114, showing 5 Applications out of 570 total, starting on record 561, ending on 565

# Protocol No Study Title Investigator(s) & Site(s)

561.

ECCT/25/11/06   MK-8527-011 Study
    A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis   
Principal Investigator(s)
1. Dr Maricianah Onono
Site(s) in Kenya
1. Nyanza Reproductive Health Society (NRHS), UNIM Research and Training Centre (URTC) (Kisumu county)
2. Kenya Impact Research and Development Organization (K-IRDO) (Kisumu county)
3. Partners for Health and Development in Africa – Sex workers Outreach Program (PHDA – SWOP) Clinic- Nairobi, Kenya (Nairobi City county)
 
View

562.

ECCT/25/11/07   MK-8527 as HIV-1 PrEP
    Protocol Title: A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis   
Principal Investigator(s)
1. John Mark Ayallo
2. Kelvin Jerry Wandera
3. John Okanda
4. Joash Diemo
5. Tobias Odwar
6. Jacob Onyango
Site(s) in Kenya
1. Kenya Impact Research and Development Organization (K-IRDO) (Kisumu county)
2. Nyanza Reproductive Health Society (NRHS), UNIM Research and Training Center (URTC) (Kisumu county)
3. Partners for Health and Development in Africa – Sex workers Outreach Program (PHDA – SWOP) (Nairobi City county)
 
View

563.

ECCT/25/12/01   Accetability testing Study
    Assessing the acceptability of enhanced multiple micronutrient supplements among pregnant women in Bungoma County       
Principal Investigator(s)
1. Zipporah Nekesa Bukania
Site(s) in Kenya
Tongaren Subcounty, Bungoma County
 
View

564.

ECCT/25/12/04   Floral Study
    An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or   thalassaemia and have completed a treatment period in an etavopivat study   
Principal Investigator(s)
1. Walter Otieno
Site(s) in Kenya
1. Kombewa Clinical Research Center (Kisumu county)
2. KEMRI Kondele Children\'s Hospital (Kisumu county)
3. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county)
4. KEMRI Siaya Clinical Research Annex (Siaya county)
5. KEMRI WALTER REED KERICHO (Kericho county)
6. Getrude\'s Children\'s Hospital (Nairobi City county)
 
View

565.

ECCT/25/12/05   Floral Study
    An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study             
Principal Investigator(s)
1. Janet Oyieko
Site(s) in Kenya
1. Kombewa Clinical Research Center (Kisumu county)
2. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county)
3. Gertrude\'s Children\'s Hospital (Nairobi City county)
4. KEMRI Siaya Clinical Research Annex (Siaya county)
5. KEMRI WALTER REED KERICHO (Kericho county)
6. KEMRI Kondele Children\'s Hospital (Kisumu county)
 
View